PDL BioPharma (PDLI): Q4 EPS of $0.17 misses by $0.02. Revenue of $58.3M (-15%) vs. $70.3M....

|About: PDL BioPharma, Inc. (PDLI)|By:, SA News Editor
PDL BioPharma (PDLI): Q4 EPS of $0.17 misses by $0.02. Revenue of $58.3M (-15%) vs. $70.3M. Shares +0.6% AH. (8-K)